Cell type | Bone marrow | Peripheral blood | ||||
---|---|---|---|---|---|---|
Mean ± SD (number) | P-valuec | Mean ± SD (number) | P-valuec | |||
Non smokers and former smokers | Active smokers at admission | Non smokers and former smokers | Active smokers at admission | |||
White cells (WC) | ||||||
Leukocytes/μL | 10,685 ± 4,818 (20) | 20,029 ± 9,943 (27) | 0.001 | 7,904 ± 2,249 (41) | 9,171 ± 2,426 (52) | 0.016 |
Haematopoietic progenitor cells | ||||||
CD45dimCD34+/μL | 49.0 ± 29.8 (20) | 83.1 ± 52.2 (28) | 0.02 | 2.7 ± 2.6 (40) | 2.8 ± 2.0 (50) | NS (0.9) |
CD45dimCD34+/105 WC | 399.3 ± 145.4 (20) | 419.0 ± 158.9 (27) | NS (0.9) | 33.7 ± 26.1 (40) | 30.8 ± 20.0 (50) | NS (0.7) |
CD45dimCD34 + CD133+/μL | 41.8 ± 24.4 (19) | 79.6 ± 52.0 (28) | 0.005 | 2.6 ± 2.6 (39) | 2.7 ± 1.9 (50) | NS (0.3) |
CD45dimCD34 + CD133+/105 WC | 394.7 ± 148.8 (19) | 402.0 ± 148.5 (27) | NS (0.4) | 32.9 ± 26.0 (39) | 29.4 ± 19.3 (50) | NS (0.7) |
CD45dimCD34 + CXCR4+/μL | 43.6 ± 25.7 (19) | 82.6 ± 52.9 (28) | 0.01 | 2.6 ± 2.6 (39) | 2.7 ± 2.0 (49) | NS (0.5) |
CD45dimCD34 + CXCR4+/105 WC | 392.1 ± 144.1 (19) | 405.5 ± 165.5 (27) | NS (0.9) | 32.7 ± 25.6 (39) | 29.5 ± 19.7 (49) | NS (0.7) |
Endothelial progenitor cells | ||||||
CD45dimCD34 + KDR+/μL | 1.5 ± 0.7 (16) | 1.8 ± 1.6 (22) | NS (0.9) | 0.2 ± 0.1 (31) | 0.1 ± 0.2 (40) | 0.02 |
CD45dimCD34 + KDR+/105 WC | 13.5 ± 7.1 (16) | 9.1 ± 8.2 (21) | 0.04 | 2.2 ± 1.9 (31) | 1.2 ± 1.8 (40) | 0.005 |
Colony-forming cell assays | ||||||
CFU-GM/1.105 BMMC or /2.105 PBMC | 68.5 ± 54.5 (16) | 95.7 ± 68.7 (22) | NS (0.2) | 13.6 ± 16.6 (39) | 18.6 ± 27.8 (53) | NS (0.4) |
CFU-EC/1.106 BMMC or /2.106 PBMC | 3.9 ± 5.3 (15) | 11.6 ± 15.0 (22) | NS (0.1) | 3.6 ± 5.7 (34) | 2.6 ± 4.4 (50) | NS (0.6) |
Migration assay | ||||||
Spontaneous migrationa | 31,374 ± 8,731 (16) | 30,877 ± 8,600 (24) | NS (0.8) | 38,613 ± 15,212 (38) | 35,383 ± 10,607 (48) | NS (0.4) |
G-CSF 100 ng/mL | 1.5 ± 0.4 (16) | 1.3 ± 0.4 (24) | 0.03 | 1.3 ± 0.4 (38) | 1.4 ± 0.3 (48) | NS (0.3) |
SDF-1α 100 ng/mLb | 1.3 ± 0.3 (16) | 1.36 ± 0.4 (24) | NS (0.9) | 1.28 ± 0.3 (38) | 1.31 ± 0.3 (48) | NS (0.6) |
VEGF 100 ng/mLb | 1.32 ± 0.3 (16) | 1.49 ± 0.5 (24) | NS (0.3) | 1.3 ± 0.3 (38) | 1.36 ± 0.4 (48) | NS (0.3) |
VEGF | ||||||
Plasmatic VEGF (pg/mL) | - | - | - | 239.5 ± 359.3 (38) | 204.7 ± 341.3 (45) | NS (0.6) |
CRP | - | - | - | 23.7 ± 27.5 (26) | 28.0 ± 35.7 (39) | NS (0.07) |